KSM Research & Innovation

What KSM Research & Innovation does

KSM Research & Innovation (Kahn-Sagol-Maccabi) is the research and innovation center of Maccabi Healthcare Services, Israel's leading HMO serving 2.7 million members. Founded in 2016 by philanthropists Morris Kahn and Sami Sagol, KSM operates from Tel Aviv with approximately 43 employees and a wholly-owned subsidiary status within the Maccabi group. The organization functions as a B2B research partnership platform, providing researchers, pharmaceutical companies, healthtech startups, and healthcare organizations with structured access to Maccabi's 30-year longitudinal digital medical records and a biobank of more than 1 million biological samples.

KSM's core product portfolio spans six internal departments: an Innovation and Big Data platform exposing online access to medical data; a Biobank supporting genetic and biological studies; Clinical Research Services functioning as a one-stop-shop for Phase II-IV interventional trials; an Epidemiological Research team publishing peer-reviewed studies; a Technology and Data Infrastructure group running R&D, cloud, data science, and engineering; and an R&D unit integrating academic, healthtech, and biotech expertise. Proprietary AI/ML models include a lung cancer risk prediction model (90.2% AUC at 6 months pre-detection) and an AI for earlier Celiac disease detection. The organization is ISO 27001, ISO 27799, and ISO 27701 certified, enabling it to handle sensitive population-scale health data commercially.

Revenue is generated through professional services-style arrangements: research partnership contracts with pharmaceutical and biotech firms (including AstraZeneca, Valo Health, PrognomiQ), clinical trial services with optimized participant recruitment, biobank-based collaborations, and an annual Research Grant Program (100,000-400,000 NIS per study). The customer base spans pharmaceutical RWE, AI-enabled healthtech startups, academic researchers, and cross-border healthcare organizations (SEHA in Abu Dhabi, Bahrain Health Ministry, UAE's G42). Go-to-market is enterprise field sales combined with event-driven engagement through scientific conferences, peer-reviewed publications, and thought-leadership content such as the 'A Matter of Life and Death' podcast.

Name

KSM Research & Innovation

Legal name

Kahn Sagol Maccabi (KSM)

Website

https://ksminnovation.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

KSM Research & Innovation is the research and innovation arm of Maccabi Healthcare Services, providing pharmaceutical companies, healthtech startups, and academic researchers with access to 30 years of longitudinal medical data on 2.7M members and a 1M+ sample biobank, supported by clinical trial services and proprietary AI/ML models.

Ownership category

akta.pro rank

Product category

Healthcare Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Clinical Trial Site Operations & Study Coordination (HLAGACAE), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Clinical research services
• Healthcare data analytics
• Biobank sample access
• Epidemiological research
• Real-world evidence

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Research Partnership Services: KSM provides data partnerships, research collaboration frameworks, and access to medical data for researchers, pharmaceutical companies, and startups. The organization operates as the innovation center of Maccabi Healthcare Services.
2. Clinical Trial Services: KSM offers expedited interventional clinical trials through optimization of participant recruitment, acting as a one-stop-shop for researchers from planning to execution.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

KSM Research & Innovation operates as the research and innovation center of Maccabi Healthcare Services, providing researchers, pharmaceutical companies, startups, and academic institutions with access to 30 years of longitudinal digital medical data covering 2.7M members, a biobank of over 1M biological samples, and a suite of clinical research and epidemiological study services. It functions as a one-stop-shop from study planning and IRB approval through to execution and potential implementation of solutions in HMO services.

Product overview

KSM Research and Innovation operates as a unified research and innovation center offering a comprehensive portfolio of healthcare data products and services. The core offerings include an Innovation and Big Data Platform providing researchers access to medical data, a large-scale Biobank with over 1M biological samples, Clinical Research Services for expedited clinical trials, Epidemiological Research capabilities, and a Technology and Data Infrastructure division. These products are complemented by a Research and Development department integrating academic research with healthtech. The center also offers the KSM Research Grant Program for funding studies and maintains a podcast series called 'A Matter of Life and Death' for scientific dissemination.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovation and Big Data Platform Online research platform providing researchers and entrepreneurs access to longitudinal medical data from 2.7M Maccabi members across demographics, medications, visits, imaging, diagnoses, laboratories, procedures, and hospitalizations, used for health research and innovation projects.
• Biobank Israel's large-scale biobank containing over 1 million biological samples, supporting genetic and biological studies for personalized healthcare research.
• Clinical Research Services One-stop-shop clinical research department providing researchers with professional knowledge and support from planning through execution, including expedited participant recruitment for Phase II-IV interventional clinical trials.
• Epidemiological Research Epidemiological studies led by research scientists that analyze disease and medication patterns using Maccabi's 30-year longitudinal digital medical data, with results published in medical and academic journals.
• Research and Development Integrates academic research, healthtech developments, and biotech company expertise to advance health innovation, including cutting-edge AI/ML methodologies such as the 90.2% AUC NSCLC risk prediction model and an AI for celiac disease detection that identifies cases 4 years earlier than traditional diagnosis.
• KSM Research Grant Program Annual research grant program funding external investigators conducting retrospective healthcare data studies (up to 100,000 NIS) and biobank-based studies (up to 400,000 NIS).

Quantifiable outcome

• Machine Learning model achieved 90.2% AUC for NSCLC risk prediction 6 months prior to clinical detection
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and major.

• AstraZenecacoreStrategic or Co-development Partner · 1 January 2025Real-world cohort study examining HER2-low status in the CDK4/6 inhibitor era conducted in collaboration with AstraZeneca for breast cancer research.
• Rhino HealthcoreStrategic or Co-development Partner · 1 January 2022KSM partnered with Rhino Health to facilitate healthcare data collaborations, enabling researchers to access and collaborate on medical data research projects.
• Genetika+coreStrategic or Co-development Partner · 1 January 2022KSM partnered with Genetika+ to seek AI solutions for personalization of depression treatment, combining genomic data with AI for precision medicine.
• PrognomiQcoreStrategic or Co-development Partner · 1 January 2022KSM partnered with PrognomiQ to improve early cancer detection, leveraging multiomics data and AI for biomarker development.
• Valo HealthcoreStrategic or Co-development Partner · 1 January 2022KSM collaboration with Valo Health focuses on advancing health data research and computational health solutions.
• IbexcoreTechnology or Integration · 1 January 2022World's first AI-powered solution for gastrointestinal cancer diagnosis deployed at Maccabi Healthcare Services, with KSM enabling the technology integration.
• SEHAmajorStrategic or Co-development Partner · 1 January 2022SEHA and KSM partnered to promote joint medical research and technological innovation, strengthening cross-border healthcare research collaboration.
• Bahrain Health MinistrymajorStrategic or Co-development PartnerKSM-Bahrain collaboration on research, enabling cross-border medical research partnerships in the Middle East.
• UAE Healthcare Entities (G42)majorStrategic or Co-development PartnerFirst collaboration in genetic research between Israel and the United Arab Emirates, focusing on cancer and diabetes research.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• TriNetX: Global RWD network for clinical research and trial feasibility, aggregating EHR data from hundreds of health systems. Comparable in enabling pharma-sponsored studies, cohort design, and site recruitment for clinical research.
• Tempus Labs: AI-powered precision medicine company combining clinical and molecular data at scale. Direct overlap with KSM's AI/ML clinical prediction models, biobank-driven genomics research, and pharma data partnerships.
• Clalit Research Institute: Research arm of Israel's largest HMO serving ~4.7M members. Closest functional peer - operates longitudinal EMR-based research, biobank, and epidemiological studies with overlapping scientific talent pool in the same Israeli market.
• Flatiron Health: US oncology-focused RWD platform originally built on EHR data; now part of Roche. Closest US analog in using longitudinal patient data to power pharma research, AI development, and clinical trial operations.
• Aetion: RWE analytics platform used by pharma and regulators to evaluate treatments using real-world data. Comparable in serving as the data-and-analytics layer for pharma outcomes research and regulatory-grade RWE generation.

Emerging players

• Owkin: Federated learning and AI biotech company focused on multi-institution healthcare data partnerships. Comparable in offering pharma AI/ML collaborations on de-identified patient data, but emerging versus KSM's more established Israeli anchor.

Broad incumbents

• Verily Life Sciences: Alphabet-owned health data and precision medicine organization running large-scale real-world cohorts and clinical research platforms. Comparable in leveraging proprietary data infrastructure to advance AI-driven health research.
• Health Catalyst: Healthcare data and analytics company serving provider systems with data warehouse, analytics, and research enablement tools. Overlaps with KSM's EMR-based data platform and population health analytics, though primarily serving US providers.
• IQVIA: Global leader in clinical research services and real-world evidence at massive scale. Overlaps with KSM's clinical trial site operations, biobank-adjacent bioservices, and RWE generation, but with vastly broader portfolio and reach.

Others

• Maccabi HMO Research (internal): Parent organization of KSM. Included as context: KSM's operational model (HMO-embedded research/innovation unit serving 2.7M members) makes the broader Maccabi Healthcare Services the closest ecosystem comparable for any HMO-anchored research spin-out.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ksminnovation
• YouTubeyoutube.com/@KSMInnovation
• Facebookfacebook.com/ksminnovation
• LinkedInlinkedin.com/company/ksm-research-innovation
• Instagraminstagram.com/ksminnovation

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KSM Research & Innovation